ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000286.1|Viguiepinol_2 # 1414 # 2949 # 1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.715	BGC0000286.1|Viguiepinol_2 	1414	2949	+	Loose	550	26.1794	LRG-1	27.08	3006941	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	LRG beta-lactamase	ATGAACGTGACCTCCTTCGCAGCCCTGCGTGCCGCGGCTCAGGACATCGTCGACGAGATGATCGCCGACCCCTACGGACTCACCTCGCCGTCGGTGTACGAGACCGCGCGGATGGTGGTGTCCGCCCCCTGGCTGGAGGGCCATCGGCAGCGCGTGGAGTTCCTGCTGGCCCAGCAGCACGAGGACGGAACGTGGGGCGGGCCTGCGGCCTACGGGCTGCTGCCCACGCTCAGCGCCGTCGACGCCCTGCTGTCCGTCGCCGGTACGCAGGACGCGCGGCGGGTCGCCGGGGCCGTGGAGTCGGGGCTGGCCGCGCTGGCCGGGCGGTTCCCCCGGAACGTCGAACTGCCGGACACCATCGCCGTGGAGCTGCTGGTGCCCTGGCTGATCGAGCAGGTCGATCAGCGGCTCTCCCGGATGGACGACCGGGGCGATCTGCCCGGCCGTCTGGACCTCCAAGCCGATACGGGAACGCTGAGCGGGATCCGCGAGCTGCTGCGTCAGAACACCGGCATACCGGAGAAGACCTGGCACTCGCTGGAGGCCCTCGGCGCCCCGGCCGTGCGGTCCGGCACGGTGACGCCGATGGGCGGGGCGGTGGGAGCCTCCCCCGCCGCCACCTCCGCCTGGCTGGGCGATCCGCCTCATACGGACGCCGCGAAGGCGTGCCTGGCGTATCTGCATCAGACCCAGGCACGTCATGGCGGCCCGGTCTCGGGCATCACCTCGATCAGCTACTTCGAACTGGCCTGGGTGGTGACGGCGTTGTCCGGCTCCGGCCTGGACGTGGACATCCCCGCCCAGGTCCCGGACATTCTGCGGACCGCGCTGGGGGCGAACGGACTGTCCGCCGGCCCGGGTCTCCCGGCCGACTCCGACGACACGTCGGCCGCCCTGCACGCCCTCGATCTCCTCGGGAAGCCGGAATCGGTCGATTGCCTGTGGGAGTACGACACCGGCCTGTACTTCACCTGCTTCCCGAAGGAACGCACCCCCTCCACCTCGACGAACGCACACATCCTCGTCGCCCTGGCGGATCGCCGCGGACAGGGCGACACGCGCTACGACCACGCCGCCGAGCGGGTGGGAGGCTGGCTCGTCGAGCAGCAGCAGCCGGACGGCCGGTGGATGGACAAGTGGCACGCCTCTCCGTACTACGCGACCGCCTGCGGCGCTGCCGCCATGGCCCGCCTGGACGGGCCGCGCACGTCCGCCGCCCTGGACGACGCCATCCGCTGGGTGCTCGACACCCAGCACGCCGACGGGTCATGGGGACGCTGGGAGGGCACCGGCGAGGAGACCGCCTATGCCCTTCAGGTGCTGAACCATCGCGCCGCCCCCGACCGACCGGCCCTCGAAGCGATCCGGGCGGGCAGGGCGTTCCTGTCAGGCCATGTCGAGGACGATCGTAGGAATCCTCCGCTGTGGCACGACAAGGACCTGTACACACCGGTCCGGGTCATCCGCGCCGAGATCCTCGGCACCCTGGCCGCGACGCAGCGCCTGGCCGAGGCCGAGAAGGAGGCACGAGCGTGA	MNVTSFAALRAAAQDIVDEMIADPYGLTSPSVYETARMVVSAPWLEGHRQRVEFLLAQQHEDGTWGGPAAYGLLPTLSAVDALLSVAGTQDARRVAGAVESGLAALAGRFPRNVELPDTIAVELLVPWLIEQVDQRLSRMDDRGDLPGRLDLQADTGTLSGIRELLRQNTGIPEKTWHSLEALGAPAVRSGTVTPMGGAVGASPAATSAWLGDPPHTDAAKACLAYLHQTQARHGGPVSGITSISYFELAWVVTALSGSGLDVDIPAQVPDILRTALGANGLSAGPGLPADSDDTSAALHALDLLGKPESVDCLWEYDTGLYFTCFPKERTPSTSTNAHILVALADRRGQGDTRYDHAAERVGGWLVEQQQPDGRWMDKWHASPYYATACGAAAMARLDGPRTSAALDDAIRWVLDTQHADGSWGRWEGTGEETAYALQVLNHRAAPDRPALEAIRAGRAFLSGHVEDDRRNPPLWHDKDLYTPVRVIRAEILGTLAATQRLAEAEKEARA	MNSIFSLSRRKYLLAAAGLTIAALFPPSVVLAEQPATLAAQLSALEASANGRLGVALIDSGSSRQLSYRGEERFAMASTFKALAAAAVLQRSVEQPALLNKRIIYQQSELITYSPVTEKHLQQGMTVAELCAAAVELSDNTAGNILLREIGGPQGITQLARRLGDNQTRLDRREPALNSAIPGDVRDTSTPLAMAGNLNQLALGKALPSAQQQLLIQWLKQSKTGAQSIRAGVPQGWQVGDKTGAGGYGTTNDLAILWPPQGKPLVLAVYFTQHNPQAEARRDVLASATRLVLAAWEKQ	170.90	gnl|BL_ORD_ID|3682|hsp_num:0	4752			231	369	
BGC0000286.1|Viguiepinol_3 # 2990 # 3877 # 1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.700	BGC0000286.1|Viguiepinol_3 	2990	3877	+	Loose	890	28.8758	cpxA	25.32	3000830	protein homolog model	n/a	n/a	aminoglycoside antibiotic; aminocoumarin antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCGTGCCCGTCACCGTGTGGCGCTGAAGGTCCTGGCCGATCTGCGGTCCTGGGCGGCGGAATACCCGCAGGTCCTCGAGGCCACGCCGATCGAAGCCCTGGCGATCTCCACCGCGGCGATCAGCCCGTGGCGCGGAGCGAACGAGCTCCGGCTGTCGGCCCCGGATGTACGCTGTGGGCCTACGCCCCTGGACGACCACGTCGAGCAGAACGTCCGGAGCCTCGACGAACTCGACGACCTGTTCGGTCGCTGCGAGGCCATCGTCCGGGGCGGCGACCGGGACGACGGCCATCCCCTGCTGGCCTCCCTGTCCGGCTGGCAGTCCGCTTTGGAGCGGGCTCCCCACTACCCGAAACTGGCCGGCCTGTGGGGCGACCGATTCGCCGAGGCCCTGCGCGGCGAGCGGTACGACTGGACCGCGGGTCTGGCCAGGGACCGCGGCGAGGGCCCTTCCGATCCGCAGGAGTACCTGACGTACGCCGCCAGCTCCAATGCGTGGATAACCCACTTCCCGCGCTGGGCGACCAGCGACCGGGACGATCTCCTCGATGGCCTGCCGGTCCTGGACAACGCCCTGGAGGCGATCGAAGTCGCCGTGCGCCTCTCCAACGACCTGGCCACCTTCGAGCGGGAGCGGGCCGAGCCCGGTCAGAACAACATCCTGATGTACGACACCTCACCCGACTGGGTGCACGACGAACTCGACCGGCATTCCCGCAAGGCGCAGGAGCAGCTCGACCCGCTGGCGACGGCCGGGTTCCCACCCGCTGTCGAGCTGCTCCGCCTGCTCGATTGGTCGGTCACCTTCTACAGCGGCGCCGACTTCCGGGGATGGGGATCCGACCGCGATCTCACCGGGCCGTCCGGCCTGCCCTCCGACATGTGA	MRARHRVALKVLADLRSWAAEYPQVLEATPIEALAISTAAISPWRGANELRLSAPDVRCGPTPLDDHVEQNVRSLDELDDLFGRCEAIVRGGDRDDGHPLLASLSGWQSALERAPHYPKLAGLWGDRFAEALRGERYDWTAGLARDRGEGPSDPQEYLTYAASSNAWITHFPRWATSDRDDLLDGLPVLDNALEAIEVAVRLSNDLATFERERAEPGQNNILMYDTSPDWVHDELDRHSRKAQEQLDPLATAGFPPAVELLRLLDWSVTFYSGADFRGWGSDRDLTGPSGLPSDM	MIGSLTARIFAIFWLTLALVLMLVLMLPKLDSRQMTELLDSEQRQGLMIEQHVEAELANDPPNDLMWWRRLFRAIDKWAPPGQRLLLVTTEGRVIGAERSEMQIIRNFIGQADNADHPQKKKYGRVELVGPFSVRDGEDNYQLYLIRPASSSQSDFINLLFDRPLLLLIVTMLVSTPLLLWLAWSLAKPARKLKNAADEVAQGNLRQHPELEAGPQEFLAAGASFNQMVTALERMMTSQQRLLSDISHELRTPLTRLQLGTALLRRRSGESKELERIETEAQRLDSMINDLLVMSRNQQKNALVSETIKANQLWSEVLDNAAFEAEQMGKSLTVNFPPGPWPLYGNPNALESALENIVRNALRYSHTKIEVGFAVDKDGITITVDDDGPGVSPEDREQIFRPFYRTDEARDRESGGTGLGLAIVETAIQQHRGWVKAEDSPLGGLRLVIWLPLYKRS	64.55	gnl|BL_ORD_ID|131|hsp_num:0	152			567	1017	novobiocin
BGC0000286.1|Viguiepinol_5 # 5355 # 6386 # 1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=3Base/5BMM;rbs_spacer=13-15bp;gc_cont=0.708	BGC0000286.1|Viguiepinol_5 	5355	6386	+	Loose	1050	27.7202	vgaALC	30.86	3002830	protein homolog model	n/a	n/a	lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; pleuromutilin antibiotic	antibiotic target protection	vga-type ABC-F protein	ATGAAATTTCGACAAGGGGAGCTGAATACGTCGACTCCACCGGCCTCGGTGGCGGGGACAGCGGAAAGCCGCCGCGCCCGCTCGGTCGGCACCGGCCGCGCCCACGCCAAGTCCATTTTGCTGGGGGAGCACGCGGTCGTCTACGGAGCCCCGGCGCTCGCCCTGCCCGTTCCGCAGCTGTCGATCACCGCCAGCGCCGGGTTCTCCAACCGCGGTGGGGAAGCGGCCGGCGTGTCCTTCACGATGACCGGATCCGCCTGGAAGCAGGTCGGAACGCAGGCATCCGAGGGGCTGCGCCGGCTGACCACCGACTTCAGGGCGTCCATGGGCATCGACGAGGGACCGCACCTCGATGTGATCATCGACGGTTCCATCCCGCTCGGCAGGGGACTTGGCTCCAGCGCGGCCTGCGCCCGTGCCGTCGTCCTCGCCCTGGCCGACCTCTGCGGCCGCGAGGTCTCGCAGCGGACGACGTTCGACCTGGTGCAGACCGCCGAGAACGTGATGCACGGCAAGGCCAGCGGCGTCGACGCCGTCACCGTGGGCGCGAGCGCCCCGTTGCTGTTCCAGGCGGGCGAGGCCCGCACGCTGCGTGTCGGCTGCGACGCGCTGTTCGTCATCGCGGACAGCGGCGCCGTCGGCAGCACCAAAGAAGCGGTCGACAAACTGCGGGAGAGGTTCCGGCTCCACGCCGGAACACAGGAGAGGTTCGTACGCCGGGCGTCGGAACTGACTGGCGAACCGGTGGCCGCCCTCGCCGCCGGCCAGCCGGAGGAGCTCGGCTCCCTGCTGACGGAGTACCACGGACTGCTCCGCGAGGCCGGGCTGAGCACCGACCGGATCGAGGCGATGGTGAGTGCCGCGCTCGCCGCAGACAGCCTCGGCGCCAAGATCACCGGCGGCGGACTGGGCGGCTGCGTCCTTGCGCTGACCCAGCCCGAGCAGGCGAGAGAGGTCACCCGGCGGCTGCACGAAGCGGGGGCCGTGCAGACGTGGATCGTCCCGCTGAGGAGGCTCGTCACTCATGTCTGA	MKFRQGELNTSTPPASVAGTAESRRARSVGTGRAHAKSILLGEHAVVYGAPALALPVPQLSITASAGFSNRGGEAAGVSFTMTGSAWKQVGTQASEGLRRLTTDFRASMGIDEGPHLDVIIDGSIPLGRGLGSSAACARAVVLALADLCGREVSQRTTFDLVQTAENVMHGKASGVDAVTVGASAPLLFQAGEARTLRVGCDALFVIADSGAVGSTKEAVDKLRERFRLHAGTQERFVRRASELTGEPVAALAAGQPEELGSLLTEYHGLLREAGLSTDRIEAMVSAALAADSLGAKITGGGLGGCVLALTQPEQAREVTRRLHEAGAVQTWIVPLRRLVTHV	MKILLEGLHIKHYVQDRLLLNINRLKIYQNDRIGLIGKNGSGKTTLLHILYKKIVPEEGIVKQFSHCELIPQLKLIESTKSGGEVTRNYIRQALDKNPELLLADEPTTNLDNNYIEKLEQDLKNWHGAFIIVSHDRAFLDNLCTTIWEIDEGRITEYKGNYSNYVEQKELERHREELEYEKYEKEKKRLEKAINIKEQKAQRATKKPKNLSSSEGKIKVTKPYFASKQKKLRKTVKSLETRLEKLERVEKRNELPPLKMDLVNLESVKNRTIIRGEDVSGTIEGRVLWKAKSFSIRGGDKMAIIGSNGTGKTTFIKKIVHGNPGISLSPSVKIGYFSQKIDTLELDKSILENVQSSSQQNETLIRTILARMHFFRDDVYKPISVLSGGERVKVALTKVFLSEVNTLVLDEPTNFLDMEAIEAFESLLKEYNGSIIFVSHDRKFIEKVATRIMTIDNKEIKIFDGTYEQFKQAEKPTRNIKEDKKLLLETKITEVLSRLSIEPSEELEQEFQNLINEKRNLDK	65.71	gnl|BL_ORD_ID|138|hsp_num:0	159			1227	1443	lincomycin; clindamycin; virginiamycin M1
BGC0000286.1|Viguiepinol_6 # 6379 # 7431 # 1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=AGGAGG;rbs_spacer=5-10bp;gc_cont=0.725	BGC0000286.1|Viguiepinol_6 	6379	7431	+	Loose	1950	30.8018	MexB	25.0	3000378	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; monobactam; carbapenem; cephalosporin; cephamycin; penam; tetracycline antibiotic; peptide antibiotic; aminocoumarin antibiotic; diaminopyrimidine antibiotic; sulfonamide antibiotic; phenicol antibiotic; penem	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGTCTGAGCAACAGATCGCCGTCCTCCGCCCGCGGGAACAGCCGGGTGCGAACGGGGTCACCGCCGTCGCGCAGCCGAACATCGCGCTGATCAAGTACTGGGGGAAGCGGGACGAGCACCTCTTCCTCCCGTGGACCAGCAGCCTGTCGATGACCCTGGACATCTTCCCCACGACCACCCGTGTCCACCTCGACGCCGAGGCCACGGACGACGAAGTGACCTTCAACGGCGCACCCGCGGCGGGCGAAGAACGGCGGCGCATCACCGGATTCCTCGATCTGGTGCGCCAACGGGCCGGGCTCACGCACCGGGCCGTCGTCGACACCCGCAACACCGTGCCCACCGGGGCGGGCCTCGCGTCCTCCGCCGGCGGGTTCGCCGCACTCGCCGTCGCCGCCGCCACCGCGTACGGACTGGACCTCGACGACACCGGTCTCTCCCGCCTGGCCCGCCGCGGCTCCGGCTCGGCCTCGCGGTCGATCTTCGGCGGCTTCGCCGTCTGGAACGCCGGCACTCCCACGGCGCCCCCTGCGGAGGCCGACCTCAGCTCCTACGCGGAGCCGGTACCTGTGGGCGACCTCGACCCCGCACTGGTCATCGCGGTGGTGAACGCCGGTCCCAAGGACGTGTCCAGCCGCGCGGCCATGCGCCGAACCGTCGAGACCTCACCCCTGTTCGAGCCCTGGGCCGCGTCGAGCCGGGACGACCTGACCGAGATGAGACAGGCGCTCCTGCGCGCCGACCTCGACGCGGTGGGCGAGATCGCCGAGCGCAACTCGCTCGGCATGCACGCGACCATGCTGAGCGCGCGCCCTGCGGTGCGCTACCTCTCGCCCGCCTCGCTCACCGTCCTCGACAGCGTGCTGCGGCTTCGGCGCGACGGCATATCGGCCTACGCGACCATGGACGCCGGACCGAATGTCAAGGTGCTCTGCCGTCGTGCGGACGCCGACCTGGTCGCCGAGGCCGTGCGCGCCGCCGCCGCGGGCGGCACCGTGCACATCGCCGGGACGGGGCAGGGCGCCCGCCTGATCGACGAGGACGGACGATGA	MSEQQIAVLRPREQPGANGVTAVAQPNIALIKYWGKRDEHLFLPWTSSLSMTLDIFPTTTRVHLDAEATDDEVTFNGAPAAGEERRRITGFLDLVRQRAGLTHRAVVDTRNTVPTGAGLASSAGGFAALAVAAATAYGLDLDDTGLSRLARRGSGSASRSIFGGFAVWNAGTPTAPPAEADLSSYAEPVPVGDLDPALVIAVVNAGPKDVSSRAAMRRTVETSPLFEPWAASSRDDLTEMRQALLRADLDAVGEIAERNSLGMHATMLSARPAVRYLSPASLTVLDSVLRLRRDGISAYATMDAGPNVKVLCRRADADLVAEAVRAAAAGGTVHIAGTGQGARLIDEDGR	MSKFFIDRPIFAWVIALVIMLAGGLSILSLPVNQYPAIAPPAIAVQVSYPGASAETVQDTVVQVIEQQMNGIDNLRYISSESNSDGSMTTTVTFEQGTDPDIAQVQVQNKLQLATPLLPQEVQRQGIRVTKAVKNFLMVVGVVSTDGSMTKEDLSNYIVSNIQDPLSRTKGVGDFQVFGSQYSMRIWLDPAKLNSYQLTPGDVSSAIQAQNVQISSGQLGGLPAVKGQQLNATIIGKTRLQTAEQFENILLKVNPDGSQVRLKDVADVGLGGQDYSINAQFNGSPASGIAIKLATGANALDTAKAIRQTIANLEPFMPQGMKVVYPYDTTPVVSASIHEVVKTLGEAILLVFLVMYLFLQNFRATLIPTIAVPVVLLGTFGVLAAFGFSINTLTMFGMVLAIGLLVDDAIVVVENVERVMAEEGLSPREAARKSMGQIQGALVGIAMVLSAVFLPMAFFGGSTGVIYRQFSITIVSAMALSVIVALILTPALCATMLKPIEKGDHGEHKGGFFGWFNRMFLSTTHGYERGVASILKHRAPYLLIYVVIVAGMIWMFTRIPTAFLPDEDQGVLFAQVQTPPGSSAERTQVVVDSMREYLLEKESSSVSSVFTVTGFNFAGRGQSSGMAFIMLKPWEERPGGENSVFELAKRAQMHFFSFKDAMVFAFAPPSVLELGNATGFDLFLQDQAGVGHEVLLQARNKFLMLAAQNPALQRVRPNGMSDEPQYKLEIDDEKASALGVSLADINSTVSIAWGSSYVNDFIDRGRVKRVYLQGRPDARMNPDDLSKWYVRNDKGEMVPFNAFATGKWEYGSPKLERYNGVPAMEILGEPAPGLSSGDAMAAVEEIVKQLPKGVGYSWTGLSYEERLSGSQAPALYALSLLVVFLCLAALYESWSIPFSVMLVVPLGVIGALLATSMRGLSNDVFFQVGLLTTIGLSAKNAILIVEFAKELHEQGKGIVEAAIEACRMRLRPIVMTSLAFILGVVPLAISTGAGSGSQHAIGTGVIGGMVTATVLAIFWVPLFYVAVSTLFKDEASKQQASVEKGQ	33.46	gnl|BL_ORD_ID|1789|hsp_num:0	1925			1896	2100	erythromycin; ciprofloxacin; tetracycline; ceftazidime; ceftriaxone; meropenem; novobiocin; azithromycin; trimethoprim; sulfamethoxazole; chloramphenicol; aztreonam; colistin A; colistin B; ampicillin; nalidixic acid; panipenem; ticarcillin; trimethoprim-sulfamethoxazole
BGC0000286.1|Viguiepinol_7 # 7428 # 8555 # 1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.733	BGC0000286.1|Viguiepinol_7 	7428	8555	+	Loose	510	28.1054	OXA-283	37.04	3001738	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGACCTCCGGGCGAACGGTCGTCCGCAGCGCGCCCGGCAAGCTGTTCGTCGCGGGCGAGTACGCGGTGGTGGAGCCCGGTACCCCGGCCGTCCTGGTGGCCGTGGACCGGGAGATCACCGTCATGGCGACCCTCTCCGACGCGGCCGACATCGTGATCTCCTCCGATCTCGTCCCCCGAGCGGTGACGTGGCGATGGCGCGACGGGCGGCTCCACGCGCCCGGCACGAAGAACGGGGACGCCGACGGGGACGGCGCACGCGGCGCACTGGCGCACGTGGTGTCAGCGGTCGAGACCGTGCGGAGACTCCTGGTCGAACGCGGCCTGCCCCTGCCCGGGCTGGAGATCTCGATCAGCAGCCGGCTGCACGACAACGGCCGCAAGTACGGCCTGGGGTCGAGCGGTGCGGTGACCGTGGCCACGATCGACGCCCTCACGTCCCTGTGCGGACTGGACCTCTCGCTCGACGCCCGGTACCGCCTGGCCGTGATCTCCTCGGCCGGGATCGACCCCAAGGGCTCCGGCGGTGACCTCGCCGCCAGTACATGGGGCGGCTGGATCGCGTACCAGGCACCCGACCGGGCCTTCGTGCTCGACCTCACCCGCCGCCACGGCATCGAGGAAGCGCTCCGCACCCCCTGGCCGGGCCTCGCGGTCCGAAGGCTTCCGGCCCCCCGCGGCCTCACCCTCGAAGTCGGCTGGACCGGCAGCCCGGCCTCGACCACCTCGCTCGTGTCCGGTCTGCACCGCCGGACCTGGCGCGGCACCGCCTCGCACCGCGCGTTCCTGGAGACCTCCACCGACTTCGTACGCGCCTCGATCACCGCCCTCGAGGCCGGCGACGACCAGAGCCTGCTGCGCCAGATCCGCCGTGCCCGGCAGGAGCTGGCCTGCCTCGACGACGAAGTCGGGCTCGGCATCTTCACACCCGAGCTGACGGCCCTGTGCGCGGTCGCCGAAACCGTCGGCGGCGCCGCCAAGCCGTCGGGCGCGGGCGGCGGCGACTGCGGCATCGCTCTGCTCGACGCCGAAGCCACGCACGACATCTCGCACGTACGGCAAGGGTGGGCCGCGGCCGGTGTGCTGGCCCTGCCCGTCCGGCCCGCCCCGAAAGGGATCGAGGAATGA	MTSGRTVVRSAPGKLFVAGEYAVVEPGTPAVLVAVDREITVMATLSDAADIVISSDLVPRAVTWRWRDGRLHAPGTKNGDADGDGARGALAHVVSAVETVRRLLVERGLPLPGLEISISSRLHDNGRKYGLGSSGAVTVATIDALTSLCGLDLSLDARYRLAVISSAGIDPKGSGGDLAASTWGGWIAYQAPDRAFVLDLTRRHGIEEALRTPWPGLAVRRLPAPRGLTLEVGWTGSPASTTSLVSGLHRRTWRGTASHRAFLETSTDFVRASITALEAGDDQSLLRQIRRARQELACLDDEVGLGIFTPELTALCAVAETVGGAAKPSGAGGGDCGIALLDAEATHDISHVRQGWAAAGVLALPVRPAPKGIEE	MKILILLPLLSCLGLTACSLPVSSLLSQSTSTQSTQAIAQLFDQAQSAGVLVIQRGQQIQVYGNDLSRADTEYVPASTFKMLNALIGLQHGKATTNEIFKWDGKKRSFAAWEKDMTLGEAMQASAVPVYQELARRIGLELMQQEVQRIQFGNQQIGQQVDNFWLVGPLKVTPKQEVQFVSALAREQLAFDPQVQQQVKAMLFLQERKAYRLYVKSGWGMDVEPQVGWLTGWVETPQAEIVAFSLNMQMRNGMDPAIRLEILQQALAELGLYPKAEG	135.87	gnl|BL_ORD_ID|2656|hsp_num:0	3448			624	771	cloxacillin; oxacillin; cefalotin
BGC0000286.1|Viguiepinol_8 # 8552 # 9643 # 1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.712	BGC0000286.1|Viguiepinol_8 	8552	9643	+	Loose	700	28.4906	oleD	29.2	3000865	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	ole glycosyltransferase	ATGAGCGTTCAGCGCAAGGACGACCACGTCCGGCTCGCCATCGAGCAGCAGGACACCCGCAGCGGGATCAATCAGTTCGACGAGGTGTCCTTCGTACACCACGCCCTGGCCGGCATCGACCGGCCGCAGGTGTCCCTGGGCACGAGCTTCGCCGGGATCTCCTGGCAGGTGCCGCTCTACATCAACGCGATGACCGGCGGCACCGCCAGGACCGGCGTCATCAACCGGGGCCTGGCGACGGCCGCCCGCGAGACCGGGGTACCCCTCGCGTCGGGCTCCGTGCACGCCTACCTCAAGGACCCGACGTGCGCCGACACCTTCCGCGTCCTGCGCCGGGAGAACCCCCACGGGTTCGTCATGGCCAACGTGAACGCGACGGCATCGGTCGCCGACACCCGGCGTGCCATCGATCTGCTGGAGGCCGACGCCCTGCAGATCCACGTCAATACGGCGCAGGAGACGGCGATGCCGGAGGGCGACCGGTCCTTCGGATCCTGGGTCTCGCAGATCGAGAAGATCACGGCGGCCGTCGACCTGCCCGTGATCGTCAAGGAGGTCGGCAACGGCCTGAGCCGCGAGACCGTCCTGACGCTGCGACAGCTGGGTGTCAGCGTGGCGGACCTCGGCGGCCGGGGCGGCACCGACTTCGCCCGCATCGAGAACGGCCGGCGCCCGCTCGGCGACTACGCCTTCCTCCACGACTGGGGCCAGTCCACCGCCGCCTGCCTCCTGGACGCGCAGGGCGCCGGTCTCCCCGTGCTCGCCTCCGGCGGCGTCCGCCATCCCCTCGACGCCGCCCGAGCCCTGGCCTTGGGCGCCTCCGGCGTCGGGGCCTCCGGAGTGTTCCCGCGCACCCTGCTCGACGGCGGTGTCGAGGCGCTGATCGCACAGATCACGAACTGGCTGGACCAGCTCGCGGCCCTGCAGACCATGCTCGGCGCACGCACCCCCGCCGAGCTCGCGAGCAAGGACCTGCTGATCCACGGCACCCTGCGAACCTTCTGCGCCGACCGGGACATCGACGCGGGGCGACTCGCCCGGCGTACCCGATCGGCCGACGCCCTCCACGATTCGACGGGAAGAGCACGATGA	MSVQRKDDHVRLAIEQQDTRSGINQFDEVSFVHHALAGIDRPQVSLGTSFAGISWQVPLYINAMTGGTARTGVINRGLATAARETGVPLASGSVHAYLKDPTCADTFRVLRRENPHGFVMANVNATASVADTRRAIDLLEADALQIHVNTAQETAMPEGDRSFGSWVSQIEKITAAVDLPVIVKEVGNGLSRETVLTLRQLGVSVADLGGRGGTDFARIENGRRPLGDYAFLHDWGQSTAACLLDAQGAGLPVLASGGVRHPLDAARALALGASGVGASGVFPRTLLDGGVEALIAQITNWLDQLAALQTMLGARTPAELASKDLLIHGTLRTFCADRDIDAGRLARRTRSADALHDSTGRAR	MTTQTTPAHIAMFSIAAHGHVNPSLEVIRELVARGHRVTYAIPPVFADKVAATGARPVLYHSTLPGPDADPEAWGSTLLDNVEPFLNDAIQALPQLADAYADDIPDLVLHDITSYPARVLARRWGVPAVSLSPNLVAWKGYEEEVAEPMWREPRQTERGRAYYARFEAWLKENGITEHPDTFASHPPRSLVLIPKALQPHADRVDEDVYTFVGACQGDRAEEGGWQRPAGAEKVVLVSLGSAFTKQPAFYRECVRAFGNLPGWHLVLQIGRKVTPAELGELPDNVEVHDWVPQLAILRQADLFVTHAGAGGSQEGLATATPMIAVPQAVDQFGNADMLQGLGVARKLATEEATADLLRETALALVDDPEVARRLRRIQAEMAQEGGTRRAADLIEAELPARHERQEPVGDRPNGG	87.47	gnl|BL_ORD_ID|1253|hsp_num:0	1367			906	1242	erythromycin; tylosin
BGC0000286.1|Viguiepinol_10 # 10704 # 11879 # 1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=3Base/5BMM;rbs_spacer=13-15bp;gc_cont=0.685	BGC0000286.1|Viguiepinol_10 	10704	11879	+	Loose	200	27.335	vanH gene in vanP cluster	30.65	3007188	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanH; glycopeptide resistance gene cluster	ATGTCCCACGAGTCTTTCTTCGGAATCCACGATCTGTCCTTCGCGACGACCGAGTACGTCCTGTCGCACGAGGCGCTCGCCGAGTACAACGGCACCGAGATCGGCAAGTACCACATCGGCATCGGCCAGCGGTCGATGAGCGTGCCCGCCGCGGACGAGGACATCGTGACGCTGGGCGCCGCCGCCGCCGCCCCGATCATCGCCCGGCACGGTTCCGGACGGATCCGAACGGTGGTCTTAGCGACGGAATCCTCGATCGACCAGGCGAAGTCCGCAGGCGTGTACGTGCACTCACTGCTCGGCCTGCCATCGGCCTGCCGCGTCGTCGAACTGAAGCAGGCCTGCTACGGAGCCACGGCCGCCCTGCAGTTCGCCATCGGACTCGTACGGCGCGACCCCGACCAGCAGGTCCTCGTGATCGCGAGCGACGTCTCCAAGTACGAACTGGACAGCCCCGGCGAGGCGACCCAGGGCGCCGCCGCGGTGGCGATGCTGGTCAGCGCCGACCCCGCCCTGGTCCGCATCGAGAACCCCTCAGGACTGTTCACGGCCGACGTCATGGACTTCTGGCGGCCGAACTACCTCACCACCGCCCTGGTCGACGGGCAGGAATCCGTCCAGGCGTACCTGCAGGCGGTCGCGAGCAGCTGGAAGGACTACGGCGAGCAGGGCGGCCGCGCACTCGACGAGTTCGCCGCGTTCTGCTACCACCAACCGTTCACGAAGATGGCCTACAAGGCACACCACCACCTGCTCAACTACGCGGGCCAGGAAACCGACAAGGCCGACATCGAGCATGCCATCGGGCGGACCGTGGCCTACAACGCCACCATCGGCAACAGCTACACCGCCTCGGTGTACCTCGCTCTCGCCGCGCTGCTCGACCAGGCGGACGACCTGACCGACCGACCCATCGGCTTCCTCAGCTACGGCTCCGGCAGCGTCGCCGAGTTCTTCGCGGGCACCGCCGCCCCCGGCTACCGCGAACACCTGCGGACCGAGGCGAACCTGGAGGCGATAGCCCGGCGCAAGCCGGTCGACCACGCCCGCTACCGCGAGCTGCACGAGCGGTCCTTCCCGGCCGACGGAGGAGAACACCTCACCCCGCAGCAGACCACCGGCCCCTTCCGCCTGGCCGGCCTCAGCGGTCACAAGCGCATCTACCAGGCGCGCTAG	MSHESFFGIHDLSFATTEYVLSHEALAEYNGTEIGKYHIGIGQRSMSVPAADEDIVTLGAAAAAPIIARHGSGRIRTVVLATESSIDQAKSAGVYVHSLLGLPSACRVVELKQACYGATAALQFAIGLVRRDPDQQVLVIASDVSKYELDSPGEATQGAAAVAMLVSADPALVRIENPSGLFTADVMDFWRPNYLTTALVDGQESVQAYLQAVASSWKDYGEQGGRALDEFAAFCYHQPFTKMAYKAHHHLLNYAGQETDKADIEHAIGRTVAYNATIGNSYTASVYLALAALLDQADDLTDRPIGFLSYGSGSVAEFFAGTAAPGYREHLRTEANLEAIARRKPVDHARYRELHERSFPADGGEHLTPQQTTGPFRLAGLSGHKRIYQAR	MREIAVLGSSEEEKKIFKKYASAYQVTLRFYENIEQVCKEGRQSLLSISHAEDMSENNLKRLHQAGVEYISTRSIGLNHIDMAAAKRLDMQVNNVAYSPESVAEHTVMLMLMALRNMKNTEKNVEQYDYRLPKKRFRELRELTVGVVGTGRIGQTVIGLLRGFGCRIICYDTYQVEGLDYVSYEELLAESDIITYHIPLTEESLHMLNQDNIRLVKPGAYIVNTARGALIDNEALIAALESGQLAGAALDVVENEESFFYKKCKNVGQELALLSRMKNVVLTPHSAFYTSQALEDVVENSIKNCLEYKEEAVYA	124.52	gnl|BL_ORD_ID|4818|hsp_num:0	5804			264	444	vancomycin; teicoplanin
BGC0000286.1|Viguiepinol_11 # 11991 # 12971 # 1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.698	BGC0000286.1|Viguiepinol_11 	11991	12971	+	Loose	850	28.8758	abeM	28.3	3000753	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; disinfecting agents and antiseptics	antibiotic efflux	multidrug and toxic compound extrusion (MATE) transporter	ATGACCGACCTCAGGATTCTCGGTACGGGTGCCTATGTGCCGGAGCGAATCGCGTCCAATGACGAGGTCGCCGCGGCGGCGGGGGTCGACGACGCGTGGATCACCGCCAAGACCGGCATCCGGGAACGGCGATGGGCTGCCGACGACCAGGCCACCTCGGACCTGGCCACCGCCGCGGGGCGGGCCGCGCTGCGGTCGGCCGGCATCACCGCCGAGGACCTGTCCGTGATCGTGGTCGCCACGTCCACACCCGACCGGCCCCAACCGCCCACCGCCGCCTACGTCCAGCAGCGGCTCGGCGCGAGCGACGCGGCCGCGTTCGACGTCAACGCGGTCTGCTCCGGCATGGTGTTCGCGCTCGCCGCGGCCGAGGGCGTACTCACCCGCACCGGCGGCCACGCACTGGTCATCGGCGCGGACCTGTATTCCCGCATCCTGAACCGGGCCGACCGCAGGACCGTGATCCTTTTCGGGGACGGTGCCGGAGCGGTGATCCTGGGGTCGTCGGTCGACCACGGACCACGTATCCGGCACCTCGCGCTGCACTCGTTCGGCGAACTGTCGGGGCTCATCGAGGTGCCCGCCGGCGGCAGTCGCATGCCCGTGGACCAGACAGTCCTCGACGCAGGGCTTCAGTACTTCGCGATGGACGGGCGAGGCGTGCGGAACTTCGTCTGTGACCACCTGCCGCAGCTGGTCAAGGGATTCCTGCACAAATGCGGTGTCGTACCCGACGACATCGACCACTTCGTACCGCACCAGGCCAACGGCACCATGCTGGACAGCCTCTTCGCCGATTTGGAACTGCCTCGCGCGACCATGCACCGCACACTGACGCACTACGCCAACACGGGAGCCGCCTCCATCCCGATCACCCTGGACGCGGCCGCCCGCGCCGGCGCCTTCAACCCCGGCGACCTGATCCTCATGGCCGGCTTCGGCGGCGGCATGTCGGCGGGATTCGCGCTGGTCGAGTGGTGA	MTDLRILGTGAYVPERIASNDEVAAAAGVDDAWITAKTGIRERRWAADDQATSDLATAAGRAALRSAGITAEDLSVIVVATSTPDRPQPPTAAYVQQRLGASDAAAFDVNAVCSGMVFALAAAEGVLTRTGGHALVIGADLYSRILNRADRRTVILFGDGAGAVILGSSVDHGPRIRHLALHSFGELSGLIEVPAGGSRMPVDQTVLDAGLQYFAMDGRGVRNFVCDHLPQLVKGFLHKCGVVPDDIDHFVPHQANGTMLDSLFADLELPRATMHRTLTHYANTGAASIPITLDAAARAGAFNPGDLILMAGFGGGMSAGFALVEW	MSNVTSFRSELKQLFHLMLPILITQFAQAGFGLIDTIMAGHLSAADLAAIAVGVGLWIPVMLLFSGIMIATTPLVAEAKGARNTEQIPVIVRQSLWVAVILGVLAMLILQLMPFFLHVFGVPESLQPKASLFLHAIGLGMPAVTMYAALRGYSEALGHPRPVTVISLLALVVLIPLNMIFMYGLGPIPALGSAGCGFATSILQWLMLITLAGYIYKASAYRNTSIFSRFDKISLTWVKRILQLGLPIGLAVFFEVSIFSTGALVLSPLGEVFIAAHQVAISVTSVLFMIPLSLAIALTIRVGTYYGEKNWASMYQVQKIGLSTAVFFALLTMSFIALGREQIVSVYTQDINVVPVAMYLLWFAMAYQLMDALQVSAAGCLRGMQDTQAPMWITLMAYWVIAFPIGLYLARYTDWGVAGVWLGLIIGLSIACVLLLSRLYLNTKRLSQT	72.77	gnl|BL_ORD_ID|1254|hsp_num:0	1368			327	612	ciprofloxacin; acriflavine; norfloxacin; ofloxacin; triclosan
BGC0000286.1|Viguiepinol_12 # 13133 # 13246 # 1 # ID=1_12;partial=00;start_type=GTG;rbs_motif=GGxGG;rbs_spacer=5-10bp;gc_cont=0.658	BGC0000286.1|Viguiepinol_12 	13133	13246	+	Loose	330	21.557	AAC(6')-Ian	64.29	3003200	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(6')	GTGGCGGAGAAGTTCGGCGGCGACTCGGTGCCCGAGACCCGGCGCAACGTCCAGTCGTACCTCGGCCAGGTGCCCCGGTACCCAATCGATTCCGAAGGCAAGGGGAACAAGTGA	MAEKFGGDSVPETRRNVQSYLGQVPRYPIDSEGKGNK	MLVQQGRLAIRALQKSDAPVMLRWLQDERVLEFYEGRDKHFDLQTVIEVFIEDQGETTPCLVLLDDKPLGYVQFYPLDSEDKQALELPVEDVIYGLDQFIGEPDFWGLGLGTELVSLVRDYLITDKAAQRLVLDPQSRNSRAIACYEKCGFEKLRLLPAHEMHEGQLQDCWLMQYYPARSSLMASSRPKI	19.47	gnl|BL_ORD_ID|2101|hsp_num:0	3319			204	246	dibekacin; amikacin; sisomicin; netilmicin; tobramycin; 2'-N-ethylnetilmicin; 5-episisomicin
BGC0000286.1|Viguiepinol_13 # 13243 # 13872 # 1 # ID=1_13;partial=00;start_type=GTG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.678	BGC0000286.1|Viguiepinol_13 	13243	13872	+	Loose	350	25.409	vanB	30.77	3000013	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; Van ligase	GTGACAGACCGTCCGTTCTACGTGCTGCTGGGGCCGGACTACGCCGGGAAGTCCTCCGTGATGACGGAGCTCTCGGCGGCGATGCCCGGCTGGCAGACCCTGTCGACCGACGACGACCTCGTGGCCGGGGAGCACCGTCTGATCTCGCAGCTGCGCCGGAACGTCGTCCGGGACGTGCTGCCGGGCCTGGGGCCCACGTACTCCGCCGACTTCCTCGCGAGTCTGCTGGGCACGGCCGTCGTGCACCTGAGGGATCAGCTCGAACGGCAGGAGCCGGACGTGCCGGTCTTGATGGACTCGTACTACTACAAGATCCTCGCGAAGTGTCGACTCGCCGGGCTTGAAATGCACCCCCTGTACACCTGGTGGCGTTCCTTTCCCCTGCCGCGCGGAGTGATCTATCTGGACGTCTCGCCCGAGACCGCCTGGCGTCGCTCGGGACGCGGAGCGCAGCTCAACCCCCTCGAGCACTTCGGCGACCGGCCCGAGTGGTTCGGCTTCGAGAGCTATCAGAAGAACCTCGGCAAGCTGTTGCTGGAGGAAACGGGACAACTGCCCGTCACGGTGGTCGAGGAGCGGTCCGGGACGGCTGCGACCGCCGCGGCCGTGCGGGAGGTCCTGGCGGCATGA	MTDRPFYVLLGPDYAGKSSVMTELSAAMPGWQTLSTDDDLVAGEHRLISQLRRNVVRDVLPGLGPTYSADFLASLLGTAVVHLRDQLERQEPDVPVLMDSYYYKILAKCRLAGLEMHPLYTWWRSFPLPRGVIYLDVSPETAWRRSGRGAQLNPLEHFGDRPEWFGFESYQKNLGKLLLEETGQLPVTVVEERSGTAATAAAVREVLAA	MNRIKVAIIFGGCSEEHDVSVKSAIEIAANIDTEKFDPHYIGITKNGVWKLCKKPCTEWEADSLPAILSPDRKTHGLLVMKESEYETRRIDVAFPVLHGKCGEDGAIQGLFVLSGIPYVGCDIQSSAACMDKSLAYILTKNAGIAVPEFQMIDKGDKPEAGALTYPVFVKPARSGSSFGVTKVNGTEELNAAIEAAGQYDGKILIEQAISGCEVGCAVMGNEDDLIVGEVDQIRLSHGIFRIHQENEPEKGSENAMITVPADIPVEERNRVQETAKKVYRVLGCRGLARVDLFLQEDGGIVLNEVNTLPGFTSYSRYPRMMAAAGITLPALIDSLITLALKR	61.11	gnl|BL_ORD_ID|1005|hsp_num:0	1098			594	702	vancomycin
BGC0000286.1|Viguiepinol_15 # 15566 # 16432 # 1 # ID=1_15;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.717	BGC0000286.1|Viguiepinol_15 	15566	16432	+	Loose	450	27.7202	Streptomyces lividans otr(A)	32.43	3007127	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	ATGATGCATGTCCAGGATCCCGTCGACCCCGTGGAGACGACTGCCCTGCTGACCGCCGCCCTGCGCGCCGCCGAGAGCGGGCGGGAGGACCGGCTCTACAAGGATCCGTACGCGGCCGCGCTGGTGGGGGACGCAGGCCCCCGGCTCCTGGCGGAGATCCGTGCCGCGACCTTCCCGCCGGACGGGCCGCGGAGCGTGCCCAGTACCCCCGACTACAACGCGATCCGCACCAGATTCTTCGATGACCTCCTCCAAGAGGCCGTACAGGACCAGGGGATGACCCAGCTCGTCGTGGCCCCGGCCGGCATGGACTCCCGTGCCTACCGGCTGCCCTGGCCGCGACACCTGCGGTACTTCGAGGTCGACCGGCCGTCGGTGCTCGCGTTCAAGGAGGAGCGCCTGCGCGGGGTCGACCCGCGCGTCGACCACGTCACCGTCGCCGTCGACCTGACCGCGGACGACTGGGAGGACCGGCTCCGCGCCTCCGGATACGACCCGAGCACGCCGTCCACCTGGCTGCTCGAAGGGCTGCTGTACTACATCCCTGAGAAGGACACCGAGCGCATGCTGGAGCGGGTCGGCGCATTCTGTGCTCCGGGCAGCCGCATCGCCGCCGACCTCGTCAACTCCGCGGCCCTCACCCTCCCGCACATGCGTCCCCTCCTGGACGTCTTCAGCGGCTGGGGCTGCCCCTGGCTCTTCGGCAGCGACGAGCCCGAGGCGCTCTTCGAGCGGTACGGCTTCGACGTGGCCGCGGTCCAGCCCGGTGAGCCCGGGGCCCACTTCGGACGCTGGCCGGACCCGGTCCCCGACCGCGCCGTCAAGGACGTGCGGCGGGTGTTCTTCGTGCACGGCCAACGCCGGTGA	MMHVQDPVDPVETTALLTAALRAAESGREDRLYKDPYAAALVGDAGPRLLAEIRAATFPPDGPRSVPSTPDYNAIRTRFFDDLLQEAVQDQGMTQLVVAPAGMDSRAYRLPWPRHLRYFEVDRPSVLAFKEERLRGVDPRVDHVTVAVDLTADDWEDRLRASGYDPSTPSTWLLEGLLYYIPEKDTERMLERVGAFCAPGSRIAADLVNSAALTLPHMRPLLDVFSGWGCPWLFGSDEPEALFERYGFDVAAVQPGEPGAHFGRWPDPVPDRAVKDVRRVFFVHGQRR	MRTLNIGILAHVDAGKTSLTERLLFDHGAVDRLGSVDAGDTRTVDGGIERRRGITIRSAVAAFTVGDTRVNLIDTPGHSDFVAEVERALEVLDGAVLLLSAVEGVQARTRVLMRALRRLRLPTIVFVNKIDRAGARTDGLLGDVRRLLTPHVAPLTEVADAGTPRARVTRRPPDGRTAEALAEVDTEVLAALVDGPEPTGEDVARALAARTADGSFHPLYHGSALGGQGVAELVEGLLGLIPAATPGTSGGTSGGTEPRGTVFAVRPGPAGERTAYLRLYGGEVHPRRRLTFLRRESDGRTTEVSGRVTRLDVVGGDATLTAGNIAALTVPGGLRVGDRLGGPTDRAPQFAPPTLQTLVRARHPEQAAPLRSALLALADQDPLLHARPAASGATALLLYGEVQMEVLAATLAEDFGIEAEFTPGRVRFLERPAGTDEAAEEMPWLDRTRYFATIGLRVEPGPRGSGGAFGYETELGALPRAFHQAVEETVHDTLRTGLTGAAVTDYRVTLIRSGFSSPLSTAADFRGLTPLVLRRALARAGTVLHEPYQAFEAEVPADTLAAVTALLASLGADFTGTTGGDPAWIVTGELPARRVREAELRLPGLTHGEAVWSSRPCEDRPLKAGNSGPGTGVGGHSGE	45.07	gnl|BL_ORD_ID|4808|hsp_num:0	5797			1236	1458	tetracycline
BGC0000286.1|Viguiepinol_16 # 16429 # 17862 # 1 # ID=1_16;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.745	BGC0000286.1|Viguiepinol_16 	16429	17862	+	Loose	760	32.7278	tet(X3)	23.29	3004719	protein homolog model	n/a	n/a	glycylcycline; tetracycline antibiotic	antibiotic inactivation	tetracycline inactivation enzyme	GTGACCGGGCCCGTCGTGGTGGGCGGCAGCGTCGCGGGGCTCGCCGCCGGCCTCGCCCTGGCGTTACGGGGCCTGCCCGTCCGGGTGCTGGAGCAGGCGCCCGTACCGCCGGAAGGGCCGCCGGGGAAGGCGGCCGAGCTGTGGAAGAGGCCCACTGTCGCGCAGAACGGCCACTCCCACGTCCTGACCTCGCTCGGCGTACGGGTGCTGCGGGCCCACGTCCCTCAGGTGCTCGACGCCGCTTTGGAGGCCGGCGCACGCATGCTCGACCTCATGCGGGCGCTGCCGGTACGGGCCGACGATGGGATCCGCCGCCAGGGCGACGAGGAACTCGTGGCCCTCGCCGTGCGCCGCCCGGTCTTCGAACTCGTCCTCCGCCAGGCGCTGCGGTCGCTGCCGAACGTCACGATCAGCCATGACGTCAAGGTCATAGGCCTGCGCACGACGCCCTCGGGGAACCGGGTGACGGGCCTGGTGACCGGCGACGGCGAGGACATCCCCACGCATACGGTCGTGGACGCCACCGGACGCCGGTCGGCGTCGCGGTCCTGGCTCACCGCCGCCGGATTTCCCCCGGAAGCCGCGAGGACCGCCCCCACCCGGGTGCGCGCCTTCACCCGCTTCTACCGGCTCAGGTCCCCCGGCACGCTGCCCGGACCGCTCAACCGCGGCAACGCGGCGGGCGGCATCTGGGACCACTACGCGGCGGTCGCACACCTCGCCGACAACGACACGTACGCCCTGACCGTCGGCGTGCCCACTGCGGATCCGGCGACGACAGGCCTGCGGCATCCGGCCGCCTTCACCGCGGTCGCCCGTCTTTCGCCGTACCTCGCCGCCTGGGCCGATCCCGCGGTGGGGGAGCCGATCAGCGCGGTGCGAGCCATCACCCTGCCGCCCAACACGCTGCACTGCGCACCCGACGCCGGCGCCGGGCCGATCGCGGGCCTGTACCCGGTCGGGGACGCCGCGTGTGTCACCGACCCGCTCTTCGGGCGGGGCATGTCGCTGGCCCTGCGGCACGCTTTCCTGCTCGCGGATTTCCTGGCGGACGAGCCGGCGGTCGAGGAGCAGGGTGAACGTGCCGCACGCATCGCCGACGGCGTCTACCGGTCGTGGTACGAGCAGTCCGTCCGCGAGGACGCGGCACGCACGGCCCTGTGGCAGGCGAGGGTCACGGGATGCCCGCCGCCGACGGTATCGGAGTCCGGCCGCGCAGCACTGTCCGAAGTCGCCCGGGCGGCGGCCGCCGACGGGACCGTGTGGCGCGGCCTCACCCGCGTGCTGATGGGCCTGGAGACCGTCGAGGACGTCTTCGACGACGAGGCGTTCCGCCGACGGGTACGGACGGCCCCCGAACCGGCCGCGGCCGCGCCGCGCCCACTGACGCGGGAGGAACTGGTCGCCGCCGTCAGAGACGAGGTGCGCGCATGA	MTGPVVVGGSVAGLAAGLALALRGLPVRVLEQAPVPPEGPPGKAAELWKRPTVAQNGHSHVLTSLGVRVLRAHVPQVLDAALEAGARMLDLMRALPVRADDGIRRQGDEELVALAVRRPVFELVLRQALRSLPNVTISHDVKVIGLRTTPSGNRVTGLVTGDGEDIPTHTVVDATGRRSASRSWLTAAGFPPEAARTAPTRVRAFTRFYRLRSPGTLPGPLNRGNAAGGIWDHYAAVAHLADNDTYALTVGVPTADPATTGLRHPAAFTAVARLSPYLAAWADPAVGEPISAVRAITLPPNTLHCAPDAGAGPIAGLYPVGDAACVTDPLFGRGMSLALRHAFLLADFLADEPAVEEQGERAARIADGVYRSWYEQSVREDAARTALWQARVTGCPPPTVSESGRAALSEVARAAAADGTVWRGLTRVLMGLETVEDVFDDEAFRRRVRTAPEPAAAAPRPLTREELVAAVRDEVRA	MTMRIDTDKQMNLLSDKNVAIIGGGPVGLTMAKLLQQNGIDVSVYERDNDREARIFGGTLDLHKGSGQEAMKKAGLLQTYYDLALPMGVNIADEKGNILSTKNVKPENRFDNPEINRNDLRAILLNSLENDTVIWDRKLVMLEPGKKKWTLTFENKPSETADLVILANGGMSKIRSFVTDTQVEETGTFNIQADILQPEINCPGFFQLCNGNRLMAGHQGILLFANPNNNGALYLGISFKTPDEWKNKIPLDFQDRNSVADFLLKRFSKWSEVYKQLIRSVSTFQCLPTRKFPLNNDWKSNRPLPITMIGDAAHLMSPFAGQGVNTGLLDALILSENLTNGEFTSIENAIENYEQQMFVYAKDTQDESTENETEMFSPNFSFQKLLNL	122.94	gnl|BL_ORD_ID|4801|hsp_num:0	3401			372	1068	tigecycline; tetracycline
BGC0000286.1|Viguiepinol_18 # 18995 # 19462 # 1 # ID=1_18;partial=01;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.737	BGC0000286.1|Viguiepinol_18 	18995	19462	+	Loose	475	26.9498	FIA-1	34.09	3006887	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	FIA beta-lactamase	ATGAGCCTCTCCCCCGAGCTGCTGCTCACCGTCGCCGCCGAACGCCTGCGGGCCGCCCGCCCCGACCTCGCGGCCCATGCGACCCCGGTCACCCCGCAATCCCTGCTCGCGGCGAAGAAGCAGATCGAGGACGACGCCGTCGGCCGCACCGACGAGGTGTCGGCGGTCGCCGTCGTCCGCGACGTCCGACTCGTCTCCTGGGTACGGGAGACCTGCGCGTTCGTGCTGTCCCTGCCGCCGGAGCAGGCCGACGCCTGGCGCCGCTCCTTCACCCGGACCCTCTACCTGGCCGGCCGCCCCGACAACCTGAGCGAGCGGTTCACTTTCGCGCACATCGCCGCCGACGGCTCGGCCGCCTGGACCGGTCCGCTGCCGGACGAGGCCACGACCGGCCTGCGCAGACTGCTCAAGACGTTCAGCGGACGAGGTCCGCTGCCGGCCTGGCGGCCCGTCACCGTCGACCTGCAG	MSLSPELLLTVAAERLRAARPDLAAHATPVTPQSLLAAKKQIEDDAVGRTDEVSAVAVVRDVRLVSWVRETCAFVLSLPPEQADAWRRSFTRTLYLAGRPDNLSERFTFAHIAADGSAAWTGPLPDEATTGLRRLLKTFSGRGPLPAWRPVTVDLQ	MRFLFILLASTLFTHLAVAQAAQKPPLRVSRLSDRVFVHTTYGMYQGEPVPSNGLIVRTDDGVVLLDTGWDTEGNTDNTRQLLRWVADSLRLPVRLCIVTHSHDDKVGGIVELQKAGIRVVSTPLTAQKTVKQGYPSPDGILPADTTFTIGNVPIRTYFPGEGHTVDNIVVWLPSERILHGGCFVKSVAAFGMGYVGESNLTAWSGSIRNVKKRFGNARIVVPGHEEWTGPQALDHTLRLLEKYNANRH	62.65	gnl|BL_ORD_ID|3532|hsp_num:0	4601			612	735	
BGC0000286.1|Viguiepinol_17 # 17859 # 18998 # 1 # ID=1_17;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.700	BGC0000286.1|Viguiepinol_17 	17859	18998	+	Loose	375	27.335	Escherichia coli AcrAB-TolC with AcrR mutation conferring resistance to ciprofloxacin, tetracycline, and ceftazidime	35.29	3003807	protein overexpression model	n/a	n/a	fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; disinfecting agents and antiseptics	antibiotic target alteration; antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGACCGCGTCGGACCGTTCCCAGACGCGCCGTCGAAAGGTGCTGCTCGCACCCGTCACGGTTACCCCGGCCAAACCGCTCACACCCAGCCACCTCAAAGGTCTGCTGTGGACCGACGTCATGTTCCGGGCCACCGCGCCGCTCGCGGACGTGACCTACCGCTACAGCCCCACGACCTACCACCTCACCGAACAGACCCTAGGATTCTGGGAGTTCCTCGACCGCACGCAGAAGGGCCTGCCCTACGCCTCACTTTCCGAGGAGGAGATCGGCGAGCTGTACGTCCGGTTCCGGGCCTGCGCGCCCCCACCGGCCGACGCCTTGCGCCCCTACGCACACCAGGTCGAGAGCAACGGCTGGGTGCACCCGGCCAGTGAACGCGTTCTGCGCCTGTGGCGCGAGCACTACGCTCAACTCGGACTCCACGACCCTGGCCTGACGGTCCATCAACCGCCAGGGCTCGGCACGGAGGAGATGATCGAACGGCTCGTCGCCCTCGGCCTGGGGCTCGACCATCGCTCCAGCGGCGGTCCCGTGTACCTCGACGCCACTCGGCACGGTCTGCCCCTGCGCCAGATCGTGACGGCGGACGGCCGCCCGAACTACCTTGCCTGCGCCCTGCGGGAACTGCTTCCGCTGGCACCCGCGTATGACGAGGTCGTGCTCCTGTACGACACCGATCTCGACGCGGACTACCGGCTGCTGCAGCGCGCGCTGACCCAGCTGGGGCCGCTGGTGCACCGCGTCCCGATCGGTCGCGTGCCCATCGACGGCACGATCAGATCGGCGCGGCACGGCGGCTGGCACGCTTACACGGCGGGCGCCCTGCTCAAGGCCGTCGGCACGGAGGCCGACGCGGACGTACGCCGTCTCGGCGTACGGCTGTACTTCGTCGCCGTCCTCGGTCCCGGACAGGCGCAGTCCTTCCGCACCGACCTGCTTCACAGGAGCCTGGACCGGGCGCGGCAGCTGCTGCGCCGGACGACCGAGCGCGGGCCCGGCACTTCGCCTCTCGTGGACGACCTGCGCCGGCACCGGCGCGACCACACCCATGTCGATCCCTATCGGCTCACCTCGTCCCTGCTGGCCCGGGCCCGCCGCACCATCGACCGCGACCTGCTCTCCACGGTGTACCTATGA	MTASDRSQTRRRKVLLAPVTVTPAKPLTPSHLKGLLWTDVMFRATAPLADVTYRYSPTTYHLTEQTLGFWEFLDRTQKGLPYASLSEEEIGELYVRFRACAPPPADALRPYAHQVESNGWVHPASERVLRLWREHYAQLGLHDPGLTVHQPPGLGTEEMIERLVALGLGLDHRSSGGPVYLDATRHGLPLRQIVTADGRPNYLACALRELLPLAPAYDEVVLLYDTDLDADYRLLQRALTQLGPLVHRVPIGRVPIDGTIRSARHGGWHAYTAGALLKAVGTEADADVRRLGVRLYFVAVLGPGQAQSFRTDLLHRSLDRARQLLRRTTERGPGTSPLVDDLRRHRRDHTHVDPYRLTSSLLARARRTIDRDLLSTVYL	MARKTKQEAQETRQHILDVALRLFSQQGVSSTSLGEIAKAAGVTRGAIYWHFKDKSDLFSEIWELSESNIGELELEYQAKFPGDPLSVLREILIHVLESTVTEERRRLLMEIIFHKCEFVGEMAVVQQAQRNLCLESYDRIEQTLKHCIEAKMLPADLMTRRAAIIMRGYISGLMENWLFAPQSFDLKKEARDYVAILLEMYLLCPTLRNPATNE	176.28	gnl|BL_ORD_ID|2090|hsp_num:0	2306			144	297	tigecycline; ciprofloxacin; tetracycline; ceftazidime; rifampin; chloramphenicol; ampicillin; cefalotin; triclosan
